MoneyWorks4Me

Strides Pharma Science informs about press release

06 Sep 2024 Evaluate
Strides Pharma Science has informed that it attached Press Release issued by the Company titled: ‘Strides receive USFDA approval for Theophylline Extended-Release Tablets, 300 mg and 450 mg’.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..